Skip to main content
Fig. 6 | Journal of Ovarian Research

Fig. 6

From: Integration of single-cell RNA-seq and bulk RNA-seq data to construct and validate a cancer-associated fibroblast-related prognostic signature for patients with ovarian cancer

Fig. 6

The responsiveness of risk score to PD-L1 blockade immunotherapy in IMvigor210 cohort. (A) Differences in risk scores among immunotherapy responses in the IMvigor210 cohort; (B) Distribution of immunotherapy responses among risk score groups in the IMvigor210 cohort; (C) Prognostic differences among risk score groups in the IMvigor210 cohort; (D) Prognostic differences between risk score groups in early stage patients in the IMvigor210 cohort; (E) prognostic differences between risk score groups in advanced patients in the IMvigor210 cohort. ****P < 0.0001

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us